Stock BXP BEXIMCO PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Beximco Pharmaceuticals Limited London S.E.

Equities

BXP

US0885792061

Delayed London S.E.
Other stock markets
 12:30:01 13/05/2024 BST 		5-day change 1st Jan Change
39 GBX 0.00% Intraday chart for Beximco Pharmaceuticals Limited +4.00% -6.02%
04-30 EARNINGS AND TRADING: Software Circle & Beximco report higher revenue AN
04-30 Beximco Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI

Evolution of the average Target Price on Beximco Pharmaceuticals Limited

Price target over the last 5 years

History of analyst recommendation changes

a192a22f417b56a6c777925fb.eJ08_Ki-Ntg9Ks4kEoelU1dS4otZBed6N3XnJHtTShI.Isxvr_rYT-8PSJFQSMHXAhwGqMIaSqMYcA2eYTISPHAJ_02b8YkEiXdJhw~ee688bffd7088442835bbd7e1f3e8e9a

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
124.1 BDT
Average target price
168.3 BDT
Spread / Average Target
+35.64%
High Price Target
198 BDT
Spread / Highest target
+59.55%
Low Price Target
150 BDT
Spread / Lowest Target
+20.87%

Consensus detail

Consensus revision (last 18 months)

Ratings for Beximco Pharmaceuticals Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. BXPHARMA Stock
  4. BXP Stock
  5. Consensus Beximco Pharmaceuticals Limited